Research sheds light on mysterious “dark genome”
Paves the way for innovative treatments targeting diseases
Read MorePosted by Staff | Dec 18, 2023
Paves the way for innovative treatments targeting diseases
Read MorePosted by Gillian Rutherford | Jan 22, 2022
Understanding drugs and viruses key to being ready for the next pandemic
Read MorePosted by Gillian Rutherford | Dec 2, 2021
Alberta invests $55.1M to taking vaccines, antiviral drugs from discovery to manufacturing
Read MorePosted by Gillian Rutherford | May 13, 2021
Molnupiravir under consideration for emergency use in India to slow the explosive spread of COVID-19 infections
Read MorePosted by Gillian Rutherford | Mar 7, 2021
Researcher sees parallels in the challenges of developing antiviral drugs for respiratory infections caused by influenza and coronaviruses
Read More